Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aardvark, ABVC, Actinium, Celldex, Ideaya, Intellia, Kymera, Mustang, Ocular, Oxurion, Pharvaris, Skye,  Sumitomo, Vaccitech.

Biopharmas raising money in public or private financings, including: Almirall, Biora, Disc, Feldan, Moat, Pharmala, Turnstone.

New hires and promotions in the biopharma industry, including: Biogen, Black Diamond, Damona, Dem, Galapagos, Generate, Jasper, Longeveron, Mei, Reata, Regulus, Senda, Tiziana, Umeå.

The top 10 med-tech stock gainers and losers for the week.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Corneat Vision, Neuronetics.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Asep Medical, Avails Medical, Biolight, Diagnostear, Myriad, Neuroone Medical, Valor Healthcare.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: .

New hires and promotions in the med-tech industry, including: Abbott Laboratories, Illumina, Precision Optics, Quest Diagnostics, Setpoint Medical.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abeona, Anthos, Astellas, Astrazeneca, Crispr, Praxis, Sanofi, Vertex, Vor.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Adverum, Alvotech, Ambulero, Avrobio, Daewoong, Hanall, Johnson & Johnson, Novartis, Ray, Teva, Vincere.